Menu
Search
|

Menu

Close
X

Hubei Biocause Pharmaceutical Co Ltd 000627.SZ (Shenzhen Stock Exchange)

7.21 CNY
+0.01 (+0.14%)
As of Feb 14
chart
Previous Close 7.20
Open 7.20
Volume 8,895,876
3m Avg Volume 27,781,500
Today’s High 7.25
Today’s Low 7.02
52 Week High 11.72
52 Week Low 6.73
Shares Outstanding (mil) 4,940.63
Market Capitalization (mil) 35,621.94
Forward P/E 15.53
Dividend (Yield %) 0.03 ( 0.35 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, CNY)
FY17
46,590
FY16
16,993
FY15
552
EPS (CNY)
FY17
0.245
FY16
0.421
FY15
0.183
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
15.53
23.34
Price to Sales (TTM)
vs sector
0.65
3.42
Price to Book (MRQ)
vs sector
2.20
2.95
Price to Cash Flow (TTM)
vs sector
--
18.04
Total Debt to Equity (MRQ)
vs sector
2.40
26.61
LT Debt to Equity (MRQ)
vs sector
0.00
19.01
Return on Investment (TTM)
vs sector
--
9.65
Return on Equity (TTM)
vs sector
14.40
22.60

EXECUTIVE LEADERSHIP

Yiqian Liu
Chairman of the Board, Since 2015
Salary: --
Bonus: --
Dali Chen
Vice Chairman of the Board, Since 2013
Salary: --
Bonus: --
Tinghao Yi
Chief Financial Officer, Since 2014
Salary: --
Bonus: --
Wenqing Shi
Executive Deputy General Manager, Director, Since 2011
Salary: --
Bonus: --
Bin Liu
Deputy General Manager, Since 2013
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Basic Materials
Industry: Commodity Chemicals
Address:

No. 132, Yangwan Road
JINGMEN   HUB   448000

Phone: +86724.2223218

Hubei Biocause Pharmaceutical Co.,Ltd. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The Company is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The Company distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.

SPONSORED STORIES